LOCUS       NP_032338                459 aa                     ROD 02-MAR-2014
DEFINITION  5-hydroxytryptamine receptor 2C [Mus musculus].
ACCESSION   NP_032338
VERSION     NP_032338.3  GI:160358831
KEYWORDS    RefSeq.
SOURCE      Mus musculus (house mouse)
  ORGANISM  Mus musculus
            Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
            Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia;
            Sciurognathi; Muroidea; Muridae; Murinae; Mus; Mus.
REFERENCE   1  (residues 1 to 459)
  AUTHORS   Berglund,E.D., Liu,C., Sohn,J.W., Liu,T., Kim,M.H., Lee,C.E.,
            Vianna,C.R., Williams,K.W., Xu,Y. and Elmquist,J.K.
  TITLE     Serotonin 2C receptors in pro-opiomelanocortin neurons regulate
            energy and glucose homeostasis
  JOURNAL   J. Clin. Invest. 123 (12), 5061-5070 (2013)
   PUBMED   24177424
  REMARK    GeneRIF: Mice lacking Htr2c specifically in POMC neurons had normal
            weight but developed glucoregulatory defects: hyperinsulinemia,
            hyperglucagonemia, hyperglycemia, & insulin resistance. These
            neurons are needed to control energy & glucose homeostasis.
REFERENCE   2  (residues 1 to 459)
  AUTHORS   Martin CB, Ramond F, Farrington DT, Aguiar AS Jr, Chevarin C,
            Berthiau AS, Caussanel S, Lanfumey L, Herrick-Davis K, Hamon M,
            Madjar JJ and Mongeau R.
  TITLE     RNA splicing and editing modulation of 5-HT(2C) receptor function:
            relevance to anxiety and aggression in VGV mice
  JOURNAL   Mol. Psychiatry 18 (6), 656-665 (2013)
   PUBMED   23247076
  REMARK    GeneRIF: These experiments thus provided a functional link between
            5-HTR2c editing, the splicing process, and the regulation of 5-HTR2c
            density and function, possibly accounting for the behavioral changes
            in VGV mice.
REFERENCE   3  (residues 1 to 459)
  AUTHORS   Pennanen L, van der Hart M, Yu L and Tecott LH.
  TITLE     Impact of serotonin (5-HT)2C receptors on executive control
            processes
  JOURNAL   Neuropsychopharmacology 38 (6), 957-967 (2013)
   PUBMED   23303047
  REMARK    GeneRIF: Impaired 5-HT2C receptor signaling during development may
            predispose to executive function disorders.
REFERENCE   4  (residues 1 to 459)
  AUTHORS   Zhang Q, Zhu Y, Zhou W, Gao L, Yuan L and Han X.
  TITLE     Serotonin receptor 2C and insulin secretion
  JOURNAL   PLoS ONE 8 (1), E54250 (2013)
   PUBMED   23349838
  REMARK    GeneRIF: Data suggest that increased expression of 5-HT(2C)R in
            pancreatic beta-cells might inhibit insulin secretion.
REFERENCE   5  (residues 1 to 459)
  AUTHORS   Du Y, Davisson MT, Kafadar K and Gardiner K.
  TITLE     A-to-I pre-mRNA editing of the serotonin 2C receptor: comparisons
            among inbred mouse strains
  JOURNAL   Gene 382, 39-46 (2006)
   PUBMED   16904273
  REMARK    GeneRIF: differences between strains were found in total editing
            frequency, in the proportion of transcripts with 1 and 4 edited
            sites, in editing frequency at the A, B, E and D sites, in amino
            acid frequencies at positions 157 and 161, and in protein isoforms.
REFERENCE   6  (residues 1 to 459)
  AUTHORS   Burns CM, Chu H, Rueter SM, Hutchinson LK, Canton H, Sanders-Bush E
            and Emeson RB.
  TITLE     Regulation of serotonin-2C receptor G-protein coupling by RNA
            editing
  JOURNAL   Nature 387 (6630), 303-308 (1997)
   PUBMED   9153397
REFERENCE   7  (residues 1 to 459)
  AUTHORS   Milatovich A, Hsieh CL, Bonaminio G, Tecott L, Julius D and Francke
            U.
  TITLE     Serotonin receptor 1c gene assigned to X chromosome in human (band
            q24) and mouse (bands D-F4)
  JOURNAL   Hum. Mol. Genet. 1 (9), 681-684 (1992)
   PUBMED   1302605
REFERENCE   8  (residues 1 to 459)
  AUTHORS   Loric S, Launay JM, Colas JF and Maroteaux L.
  TITLE     New mouse 5-HT2-like receptor. Expression in brain, heart and
            intestine
  JOURNAL   FEBS Lett. 312 (2-3), 203-207 (1992)
   PUBMED   1426253
REFERENCE   9  (residues 1 to 459)
  AUTHORS   Matsuuchi L, Gold MR, Travis A, Grosschedl R, DeFranco AL and Kelly
            RB.
  TITLE     The membrane IgM-associated proteins MB-1 and Ig-beta are sufficient
            to promote surface expression of a partially functional B-cell
            antigen receptor in a nonlymphoid cell line
  JOURNAL   Proc. Natl. Acad. Sci. U.S.A. 89 (8), 3404-3408 (1992)
   PUBMED   1373499
REFERENCE   10  (residues 1 to 459)
  AUTHORS   Foguet M, Nguyen H, Le H and Lubbert H.
  TITLE     Structure of the mouse 5-HT1C, 5-HT2 and stomach fundus serotonin
            receptor genes
  JOURNAL   Neuroreport 3 (4), 345-348 (1992)
   PUBMED   1381232
COMMENT     REVIEWED REFSEQ: This record has been curated by NCBI staff. The
            reference sequence was derived from AK034512.1, AK079648.1 and
            BC098327.1.
            On Nov 16, 2007 this sequence version replaced gi:31542977.
            Summary: Serotonin (5-hydroxytryptamine, 5-HT), a neurotransmitter,
            elicits a wide array of physiological effects by binding to several
            receptor subtypes, including the 5-HT2 family of
            seven-transmembrane-spanning, G-protein-coupled receptors, which
            activate phospholipase C and D signaling pathways. This gene
            encodes the 2C subtype of serotonin receptor and its mRNA is
            subject to multiple RNA editing events, where genomically encoded
            adenosine residues are converted to inosines. RNA editing is
            predicted to alter amino acids within the second intracellular loop
            of the 5-HT2C receptor and generate receptor isoforms that differ
            in their ability to interact with G proteins and the activation of
            phospholipase C and D signaling cascades, thus modulating
            serotonergic neurotransmission in the central nervous system.
            Studies in rodents show altered patterns of RNA editing in response
            to drug treatments and stressful situations. [provided by RefSeq,
            Jul 2008].
            Publication Note:  This RefSeq record includes a subset of the
            publications that are available for this gene. Please see the Gene
            record to access additional publications.
            ##Evidence-Data-START##
            Transcript exon combination :: AK034512.1, M63685.1 [ECO:0000332]
            RNAseq introns              :: single sample supports all introns
            SRS307261, SRS362206 [ECO:0000348]
            ##Evidence-Data-END##
            ##RefSeq-Attributes-START##
            undergoes RNA editing :: PMID: 17307311, 17287521, 16904273,
            9153397
            ##RefSeq-Attributes-END##
FEATURES             Location/Qualifiers
     source          1..459
                     /strain="C57BL/6"
                     /map="X 68.46 cM"
                     /organism="Mus musculus"
                     /chromosome="X"
                     /db_xref="taxon:10090"
     Protein         1..459
                     /note="serotonin receptor 2C; 5-HT1C; 5-HT-1C; 5-HT-2C;
                     5-hydroxytryptamine receptor 1C; 5-HT2C receptor"
                     /product="5-hydroxytryptamine receptor 2C"
                     /calculated_mol_wt="51798"
     Site            54..79
                     /note="propagated from UniProtKB/Swiss-Prot (P34968.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          64..>270
                     /note="Serpentine type 7TM GPCR chemoreceptor Srx;
                     pfam10328"
                     /db_xref="CDD:255910"
                     /region_name="7TM_GPCR_Srx"
     Region          77..369
                     /note="7 transmembrane receptor (rhodopsin family);
                     pfam00001"
                     /db_xref="CDD:249497"
                     /region_name="7tm_1"
     Site            91..111
                     /note="propagated from UniProtKB/Swiss-Prot (P34968.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            129..151
                     /note="propagated from UniProtKB/Swiss-Prot (P34968.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          135..140
                     /note="propagated from UniProtKB/Swiss-Prot (P34968.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist binding (By similarity)"
     Region          152..154
                     /note="propagated from UniProtKB/Swiss-Prot (P34968.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="DRY motif, important for ligand-induced
                     conformation changes (By similarity)"
     Site            172..194
                     /note="propagated from UniProtKB/Swiss-Prot (P34968.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            215..236
                     /note="propagated from UniProtKB/Swiss-Prot (P34968.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Site            313..334
                     /note="propagated from UniProtKB/Swiss-Prot (P34968.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          325..329
                     /note="propagated from UniProtKB/Swiss-Prot (P34968.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="Agonist binding (By similarity)"
     Site            350..372
                     /note="propagated from UniProtKB/Swiss-Prot (P34968.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /site_type="transmembrane region"
     Region          365..369
                     /note="propagated from UniProtKB/Swiss-Prot (P34968.2)"
                     /inference="non-experimental evidence, no additional
                     details recorded"
                     /region_name="NPxxY motif, important for ligand-induced
                     conformation changes and signaling (By similarity)"
     Region          457..459
                     /note="propagated from UniProtKB/Swiss-Prot (P34968.2)"
                     /experiment="experimental evidence, no additional details
                     recorded"
                     /region_name="PDZ-binding"
     CDS             1..459
                     /coded_by="NM_008312.4:689..2068"
                     /gene="Htr2c"
                     /gene_synonym="5-HT2C; 5-HT2cR; 5-HTR2C; 5HT1c; Htr1c; SR1"
                     /db_xref="CCDS:CCDS30459.1"
                     /db_xref="GeneID:15560"
                     /db_xref="MGI:MGI:96281"
ORIGIN
        1 mvnlgtavrs llvhligllv wqfdisispv aaivtdtfns sdggrlfqfp dgvqnwpals
       61 ivviiimtig gnilvimavs mekklhnatn yflmslaiad mlvgllvmpl sllailydyv
      121 wplprylcpv wisldvlfst asimhlcais ldryvairnp iehsrfnsrt kaimkiaivw
      181 aisigvsvpi pviglrdesk vfvnnttcvl ndpnfvligs fvaffiplti mvityfltiy
      241 vlrrqtlmll rghteeelrn islnflkccc kkgdeeenap npnpdqkprr kkkekrprgt
      301 mqainnekka skvlgivffv flimwcpffi tnilsvlcgk acnqklmekl lnvfvwigyv
      361 csginplvyt lfnkiyrraf skylrcdykp dkkppvrqip rvaatalsgr elnvniyrht
      421 nervvrkand tepgiemqve nlelpvnpsn vvserissv
//
